Journal of Commercial Biotechnology: July 2012 issue now available

June 27, 2012 - PRLog -- Journal of Commercial Biotechnology Vol 18, Issue 2 (2012)

EDITORIAL
Could personalized medicine be the driver for widespread price controls?
Yali Friedman

COMMENTARY
Innovating in the New Austerity   
G. Steven Burrill   

ARTICLES
Innovative biotechnology industry strategies in the U.S.’ rapidly evolving payer environment
Sarah Stanton Collins, Will Collins   

Biotechnology in Argentina: Development and Resources  
Claudia Zylberberg, Asli Ceylan Oner, Ezequiel Zylberberg

CASE STUDY
Creating systemic oral transmucosal drug delivery strategies: Case study of APL-130277
Anthony Giovinazzo, Nathan Bryson, Timothy Tankosic   

What do hospital labs really need to streamline diagnostic testing: Apple vs. Microsoft environment?
Doug Millar, John Melki   

FROM THE CLASSROOM
A general model for training the next generation of Biotechnology entrepreneurs based on recent experience of USA-UK-South Africa collaborations
Karl J. Kunert, Blessed Okole, Barend J. Vorster, Nicholas J. Brewin, Christopher A. Cullis   

FROM THE BOARDROOM
Biomarketing strategy and tactics 101 PART II of III
Dimitris Dogramatzis   

Disaster Planning for Biotechnology Companies
Frank Goudsmit   

LEGAL AND REGULATORY UPDATE
Are laboratory notebooks necessary in a first inventor to file world?
Deborah L. Lu, Thomas Kowalski, Smitha Uthaman

Mayo “nays”: The Supreme Court says no to patenting laws of nature
Jennifer A. Camacho

EU Legal & Regulatory Update   
Ewan Grist   

CONFERENCE REPORT
Drug discovery & Development Landscape: New Trends in Academia-Industry Partnerships   
Vasu Pestonjamasp

For more, see the Journal of Commercial Biotechnology at http://CommercialBiotechnology.com